TY - JOUR
T1 - Double-blind comparison of buspirone and clorazepate in anxious outpatients
AU - Cohn, Jay B.
AU - Bowden, Charles L.
AU - Fisher, Johnnie G.
AU - Rodos, J. Jerry
PY - 1986/3/31
Y1 - 1986/3/31
N2 - Buspirone, a new nonbenzodiazepine anxiolytic agent, was compared with clorazepate in a double-blind, multicenter trial conducted with 336 outpatients who had moderate to severe anxiety. The two treatments were equally effective for relief of symptoms, including anxiety with associated depression. Although both agents were generally well tolerated, the profile of side effects was dissimilar. Drowsiness and depression occurred significantly (p <0.055) more frequently with clorazepate, whereas nausea and headache occurred significantly (p <0.055) more frequently with buspirone. Clorazepate-treated patients were significantly (p <0.055) more likely to have had an adverse experience that was considered drug related or that interfered with the therapeutic effect. In this study, buspirone was shown to be an effective antianxiety agent, causing significantly less sedation than clorazepate.
AB - Buspirone, a new nonbenzodiazepine anxiolytic agent, was compared with clorazepate in a double-blind, multicenter trial conducted with 336 outpatients who had moderate to severe anxiety. The two treatments were equally effective for relief of symptoms, including anxiety with associated depression. Although both agents were generally well tolerated, the profile of side effects was dissimilar. Drowsiness and depression occurred significantly (p <0.055) more frequently with clorazepate, whereas nausea and headache occurred significantly (p <0.055) more frequently with buspirone. Clorazepate-treated patients were significantly (p <0.055) more likely to have had an adverse experience that was considered drug related or that interfered with the therapeutic effect. In this study, buspirone was shown to be an effective antianxiety agent, causing significantly less sedation than clorazepate.
UR - http://www.scopus.com/inward/record.url?scp=0022627813&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0022627813&partnerID=8YFLogxK
U2 - 10.1016/0002-9343(86)90326-8
DO - 10.1016/0002-9343(86)90326-8
M3 - Article
C2 - 2870640
AN - SCOPUS:0022627813
VL - 80
SP - 10
EP - 16
JO - American Journal of Medicine
JF - American Journal of Medicine
SN - 0002-9343
IS - 3 SUPPL. 2
ER -